Concepedia

Daniil Polykovskiy

DP

Statistics

Publications

19

Citations

3.5K

H-Index

18

Active since

2018

Affiliations

Insilicos (United States)(Current)

Insilico Medicine (United States)

Hong Kong Science and Technology Parks Corporation

Vector Institute

Canadian Institute for Advanced Research

Daniil Polykovskiy is an author at Insilicos (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2018–2025

19

Publications

19

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper et al. · Nature Biotechnology · 2019 · 1.5K citations

, , +14

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 326 citations · Full text

, , +8

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Daniil Polykovskiy, Alexander Zhebrak, Dmitry Vetrov et al. · Molecular Pharmaceutics · 2018 · 283 citations · Full text

, , +9

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · 270 citations · Full text

, , +17

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Yan A. Ivanenkov, Daniil Polykovskiy, Dmitry S. Bezrukov et al. · Journal of Chemical Information and Modeling · 2023 · 197 citations · Full text

, , +17

1–5 of 19